The GLP-1 Companion review looks at a support supplement designed to work alongside other GLP-1 approaches
First relating to the dose, most studies resulting in improvements in CTS symptoms were based on doses ranging from 50 to 300 mg daily, with no adverse symptoms seen for people with an intake of less than 500 mg/day
any gout flare-ups might necessitate re-evaluation of niacinamide therapy
Gunpowder Bark: Traditionally used for its laxative properties, aiding in digestive health
But a recent review of the literature by researchers at the University of Virginia raised a flag: they found that while GLP-1 drug therapy clearly reduces body weight and fat, these benefits dont translate into significant improvements in VO2max or overall cardiorespiratory fitness (2)
They do not prove that the same results occur in humans, and they cannot establish an appropriate human dose, safety profile or treatment schedule